Radcliffe Capital Management’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100,000
Closed -$17.5K 286
2023
Q3
$17.5K Hold
100,000
﹤0.01% 284
2023
Q2
$13.5K Hold
100,000
﹤0.01% 374
2023
Q1
$17.4K Buy
100,000
+90,000
+900% +$15.2K ﹤0.01% 448
2022
Q4
$102K Hold
10,000
﹤0.01% 860
2022
Q3
$99K Hold
10,000
﹤0.01% 1181
2022
Q2
$99K Hold
10,000
﹤0.01% 1231
2022
Q1
$99K Buy
+10,000
New +$1.68K ﹤0.01% 1210

Other funds holding NVACR

Radcliffe Capital Management's NVACR Position: Q4 2023 in Review

Radcliffe Capital Management sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2023, closing a stake of 100,000 shares — an estimated $17.5K sold.

Radcliffe Capital Management first reported a position in NVACR in Q1 2022 and held it in 7 quarters. The position peaked at $102K in Q4 2022. 32 funds tracked by Wall St. Rank hold NVACR as of Q4 2023.

  • Radcliffe Capital Management reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 100,000 NorthView Acquisition Corporation Rights shares in Q4 2023, an estimated $17.5K.
  • Radcliffe Capital Management first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 7 quarters.
  • Radcliffe Capital Management's NorthView Acquisition Corporation Rights position peaked at $102K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.